CN104826065A - Medicine for treating gastric ulcer - Google Patents
Medicine for treating gastric ulcer Download PDFInfo
- Publication number
- CN104826065A CN104826065A CN201510251069.6A CN201510251069A CN104826065A CN 104826065 A CN104826065 A CN 104826065A CN 201510251069 A CN201510251069 A CN 201510251069A CN 104826065 A CN104826065 A CN 104826065A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- gastric ulcer
- spleen
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating gastric ulcer. The medicine is prepared from the following raw medicinal materials in parts by weight: 20 parts of clovershrub, 8 parts of cornutcd pugionium, 6 parts of ginger, 9 parts of white atractylodes rhizome and 9 parts of bletilla. The medicine disclosed by the invention applies the following functions: clovershrub is capable of promoting spleen and stomach channels, and clearing heat and promoting diuresis; cornutcd pugionium is capable of entering stomach channels, and promoting qi and relieving pain; a small amount of ginger is capable of entering spleen and stomach channels, and eliminating cold to relieve pain; white atractylodes rhizome is capable of entering spleen and stomach, strengthening spleen and benefiting qi, and eliminating dampness and inducing diuresis; bletilla is capable of entering stomach channels, astringing to stop bleeding, and diminishing swelling and promoting granulation. The various medicines are co-used to act the effects of tonifying spleen and eliminating dampness, diminishing swelling and relieving pain, and astringing and promoting granulation, and effectively treat gastric ulcer. Clinical experiments prove that the medicine disclosed by the invention can be safely and effectively applied to treating gastric ulcer.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of gastric ulcer.
Background technology
Gastric ulcer is the modal disease of digestive system, cause primarily of helicobacter pylori, its main clinic symptoms is epigastrium pain, glutted belch, hungry uncomfortable or pantothenic acid, perforation, hematemesis and melena, canceration etc. can be there is in severe patient, and the course of disease is long easily repeatedly, brings great impact to the life of patient and health.In recent years, the method for the treatment of gastric ulcer is a lot, but clinical efficacy is not remarkable, and relapse rate is high.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of gastric ulcer, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing chronic gastritis.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for gastric ulcer, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Campylotropis Hirtella (Herba Myrsines Africanae) 20 parts, Herba Pugionii Cornuti 8 parts, 6 parts, Rhizoma Zingiberis Recens, the Rhizoma Atractylodis Macrocephalae 9 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 9 parts.
The present invention uses: Radix Campylotropis Hirtella (Herba Myrsines Africanae) leads to taste warp, clearing away heat-damp and promoting diuresis; Herba Pugionii Cornuti enters stomach warp, promoting the circulation of QI to relieve pain; Rhizoma Zingiberis Recens is a small amount of, enters taste warp, dispersing cold for relieving pain; The Rhizoma Atractylodis Macrocephalae enters taste, invigorating the spleen and benefiting QI; Dampness diuretic; The Pseudobulbus Bletillae (Rhizoma Bletillae) enters stomach warp, astringing to arrest bleeding, detumescence and promoting granulation.All medicines share, and play effect of the spleen strengthening and damp drying, reducing swelling and alleviating pain, convergence granulation promoting altogether, effectively cure gastric ulcer.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Clarify a diagnosis as gastric ulcer under collecting outpatient service and gastroscope of being in hospital between year October altogether and be in patients with active's totally 60 examples in inventor in October, 2011 ~ 2014.
Get rid of: upper gastrointestinal operation history; Massive bleeding from upper digestive tract, bore a hole, the severe complication patient such as to block; Gestation or breast-feeding female; The patient of long-term taking antiinflammatory or steroid medicine; The patient of the serious heart, kidney, hepatic insufficiency.
Be divided into treatment group and matched group at random according to medical order, often organize 30 examples.Treatment group man 16 example, female 14 example, 19 ~ 44 years old age, average (31.5 ± 11.3) year.Matched group man 15 example, female 15 example, 18 ~ 46 years old age, average (32.2 ± 11.7) year.Two groups of patients are all shown as gastric ulcer A1 or A2 phase through gastroscopy, all have upper abdominal pain, swollen and burn feeling in various degree.Two groups of patient's physical data comparing difference not statistically significants (JP > 0.05), have comparability.
2, test method
2.1 Therapeutic Method
The decoct that the oral the present invention for the treatment of group obtains according to embodiment 1, every day 3 times.6 weeks courses for the treatment of.
The oral SANJIU WEITAI of a matched group capsule (China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.), each 20g, every day 3 times.6 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Effective: sign and subjective symptoms disappear completely, see that ulcer surface disappears or cicatrization completely through gastroscopy, local is without edema or congested phenomenon.
Effective: sign and subjective symptoms disappear or significantly alleviate, detect through gastroscope and see that ulcer surface reduces more than 3/4.
Invalid: through gastroscope, sign and subjective symptoms all without improvement, are even more seriously shown in that ulcer area does not change or becomes large.
3.2 therapeutic outcomes are in table 1.
Table 1 liang group comparitive study
| Group | n | Effective | Effectively | Invalid | Total effective rate (%) | Untoward reaction example |
| Treatment group | 30 | 15 | 12 | 3 | 90％ | 0 |
| Matched group | 30 | 1 | 20 | 9 | 70％ | 0 |
Visible, the medicine that the present invention obtains can safe and effective treatment chronic gastritis, has promotional value.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Radix Campylotropis Hirtella (Herba Myrsines Africanae) 20 grams, Herba Pugionii Cornuti 8 grams, 6 grams, Rhizoma Zingiberis Recens, the Rhizoma Atractylodis Macrocephalae 9 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 9 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of chronic gastritis.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Radix Campylotropis Hirtella (Herba Myrsines Africanae) 20 grams, Herba Pugionii Cornuti 8 grams, 6 grams, Rhizoma Zingiberis Recens, the Rhizoma Atractylodis Macrocephalae 9 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 9 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of chronic gastritis.Oral, daily once.
Embodiment 3
Take: Radix Campylotropis Hirtella (Herba Myrsines Africanae) 20 grams, Herba Pugionii Cornuti 8 grams, 6 grams, Rhizoma Zingiberis Recens, the Rhizoma Atractylodis Macrocephalae 9 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 9 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of chronic gastritis.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. be used for the treatment of a medicine for gastric ulcer, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Campylotropis Hirtella (Herba Myrsines Africanae) 20 parts, Herba Pugionii Cornuti 8 parts, 6 parts, Rhizoma Zingiberis Recens, the Rhizoma Atractylodis Macrocephalae 9 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 9 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510251069.6A CN104826065A (en) | 2015-05-14 | 2015-05-14 | Medicine for treating gastric ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510251069.6A CN104826065A (en) | 2015-05-14 | 2015-05-14 | Medicine for treating gastric ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104826065A true CN104826065A (en) | 2015-08-12 |
Family
ID=53804507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510251069.6A Pending CN104826065A (en) | 2015-05-14 | 2015-05-14 | Medicine for treating gastric ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104826065A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711836A (en) * | 2009-12-18 | 2010-05-26 | 威海博力生物工程有限公司 | Preparation used for treating gastritis and gastric ulcer and protecting gastric mucous membranes |
| CN103599367A (en) * | 2013-11-15 | 2014-02-26 | 刘桂沅 | Capsule for gastrointestinal ulcer and preparation technology thereof |
| CN104383285A (en) * | 2014-12-01 | 2015-03-04 | 马喜超 | Traditional Chinese medicine for treating gastrosis and preparation method of traditional Chinese medicine |
-
2015
- 2015-05-14 CN CN201510251069.6A patent/CN104826065A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711836A (en) * | 2009-12-18 | 2010-05-26 | 威海博力生物工程有限公司 | Preparation used for treating gastritis and gastric ulcer and protecting gastric mucous membranes |
| CN103599367A (en) * | 2013-11-15 | 2014-02-26 | 刘桂沅 | Capsule for gastrointestinal ulcer and preparation technology thereof |
| CN104383285A (en) * | 2014-12-01 | 2015-03-04 | 马喜超 | Traditional Chinese medicine for treating gastrosis and preparation method of traditional Chinese medicine |
Non-Patent Citations (1)
| Title |
|---|
| 王寿华: "大红袍治疗胃病浅析", 《中国民族民间医药杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN101700358A (en) | Medicine for treating acute and chronic nonspecific ulcerative colitis and preparation method thereof | |
| CN103182019B (en) | Traditional Chinese medicine composition for treating ROU (recurrent oral ulcer) | |
| CN102772694B (en) | Traditional Chinese medicine composition for treating wind-heat type common cold | |
| CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN102552512A (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN104491420A (en) | Enema traditional Chinese medicinal composition for treating ulcerative colitis, and preparation method thereof | |
| CN103610831B (en) | A kind of Chinese medicine for the treatment of neck and shoulder pain | |
| CN104826065A (en) | Medicine for treating gastric ulcer | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN104548033A (en) | Copperleaf-herb traditional Chinese medicine preparation for treatment of enteritis and preparation method thereof | |
| CN102727837B (en) | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis | |
| CN103893675A (en) | Traditional Chinese medicinal preparation for treating epigastric pain | |
| CN101961474B (en) | Chinese medicinal preparation for treating gastrointestinal diseases | |
| CN102805851B (en) | Method for preparing traditional Chinese medicine for treating qi deficiency type acute glomerulonephritis | |
| CN105232662A (en) | Medicine for treating chronic colitis | |
| CN106138421A (en) | Chinese medicine composition for the treatment of enteritis and preparation method and application | |
| CN105381129A (en) | Medicine for treating simple goiter | |
| CN105663553A (en) | Medicine for treating female infertility | |
| CN104721774A (en) | Traditional Chinese medicine for treating chronic colitis | |
| CN102205085B (en) | Anti-ulcer powder for treating stomach disease | |
| CN104147522A (en) | Pharmaceutical composition for treating upper gastrointestinal hemorrhage | |
| CN103356957B (en) | Medicine for treating stomach cancer and preparation method thereof | |
| CN103006933B (en) | Traditional Chinese medicine for treating atrophic rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |
|
| WD01 | Invention patent application deemed withdrawn after publication |